Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

THRX 23.88 -1.44 (-5.69%)
price chart
Investor's Watch List - Terex Corporation (NYSE:TEX), Theravance Inc(NASDAQ ...
Las Vegas, NV - July 24, 2014 - (Tech Sonian) �Terex Corporation (NYSE:TEX) recently declared income from continuing operations of $87.8 million, or $0.76 per share, for the second quarter of 2014.
Theravance, Inc. Appoints Theodore J. Witek, Jr. as Senior Vice President ...
SOUTH SAN FRANCISCO, CA, Jul 02, 2014 (Marketwired via COMTEX) -- Theravance, Inc. (NASDAQ:THRX) ("Theravance"), A Royalty Management Company, today announced the appointment of Theodore J. Witek, Jr.
Related articles »  
Stocks Buzz: American Airlines Group Inc (NASDAQ:AAL), Theravance Inc ...
Imperial Capital raises their American Airlines Group Inc(NASDAQ:AAL) tgt to $55 from $46. AAL remains one of their top picks in the sector as they expect the new mgmt team to continue to make structural changes to legacy AMR operations which should ...
Related articles »  
Morning Alert � Rite Aid Corporation (NYSE:RAD), Visteon Corp (NYSE:VC ...
Theravance Inc (NASDAQ:THRX) and GlaxoSmithKline plc announced the start of a global phase III study, known as IMPACT, to evaluate the efficacy and safety of the 'closed' triple combination of FF/UMEC/VI in patients with chronic obstructive pulmonary ...
Volume Buzz: Medivation, Inc. (NASDAQ:MDVN), Theravance Inc. (NASDAQ ...
Lakeway, NY - (MARKET NEWS CALL) - 7/07/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
How Bulls Walk in Biotech Industry- Agenus Inc (NASDAQ:AGEN), Arrowhead ...  eMarketsDaily
Related articles »  
Biotech Active Movers: Theravance Inc. (NASDAQ:THRX), CytRx Corporation ...
On 13 JuneGlaxoSmithKline plc and Theravance, Inc. (NASDAQ:THRX) announced positive results from two phase III studies, which showed that patients with chronic obstructive pulmonary disease (COPD) who received the anticholinergic, Incruse Ellipta ...
Related articles »  
News Recap: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Theravance Inc ...
Lakeway, NY - (MARKET NEWS CALL) - 6/30/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Theravance/Glaxo Commence Global Late stage Study on COPD - Analyst Blog
Theravance, Inc. ( THRX ) and partner GlaxoSmithKline ( GSK ) announced the commencement of a phase III study (IMPACT: n=10,000) to evaluate the safety and efficacy of a triple combination treatment in patients suffering from chronic obstructive ...
GSK and Theravance Announce Initiation of Phase III Programme With Fixed ...  Marketwired (press release)
Related articles »  
Biotech Overbought Stocks: Idenix Pharmaceuticals Inc (NASDAQ:IDIX ...
On 12 JUNE Theravance Inc (NASDAQ:THRX) announced the appointment of George B. Abercrombie, Senior Vice President, Corporate Partnerships, Commercial.
GSK and Theravance Announce Submission to US Regulatory Authorities for ...
LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA, Jun 30, 2014 (Marketwired via COMTEX) -- GlaxoSmithKline plc (LSS:UK:GSK) (NYSE:GSK) and Theravance, Inc. (NASDAQ:THRX) today announced the submission of a supplemental New ...
Glaxo/Theravance Seek to Expand Breo Elliptas Label  Zacks.com
Related articles »